The Bank of England’s plan to introduce a government-backed digital currency has faced delays due to worries about people’s privacy. This information comes from a senior member of the project.
Myma Medical, a company that emerged from the University of Birmingham in 2020, has created the ‘AutoICSI’ system to enhance the success rates of IVF treatments.
AutoICSI utilizes AI-powered cameras to detect the positioning of eggs before injection, as well as assessing the shape, size, and movement of sperm to ensure the correct sample is used at the right time.
Myma Medical claims that the AutoICSI system can significantly reduce the number of costly and often unsuccessful IVF attempts before a successful one is achieved.
The cost of a single IVF cycle can reach as high as £12,000, with a success rate of 54.5% for women under 35 and 41.1% for women aged 35 to 37, declining further with age, according to CDC research.
Yash Khandhia, CEO of Myma Medical, stated that the investment from LYVA Labs will accelerate the development of AutoICSI and its associated AI-based high-definition vision camera system, enabling the company to prepare for clinical trials and regulatory approval before commercialization.
LYVA Labs had previously invested £105,000 in Myma Medical in 2022, and this latest funding round increases their total investment in the company to £779,000. Myma Medical has also received over £500,000 in funding from multiple Innovate UK schemes.
Lorna Green, CEO of LYVA Labs, commented that Myma Medical is developing technology that could significantly improve the success of fertility treatments, benefiting families across the UK.
Important: Please note that this article is only meant to provide information and should not be taken as legal, tax, investment, financial, or any other type of advice.
Join Cryptos Headlines Community
Follow Cryptos Headlines on Google News
